Citi Pharma Ltd. — Investor Relations & Filings
Citi Pharma Ltd. is a prominent pharmaceutical company specializing in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. It is a leading producer of Active Pharmaceutical Ingredients (APIs), with key products including Paracetamol, Penicillin, and Amoxicillin. The company delivers high-quality pharmaceutical services to a global market while maintaining a significant presence in local API manufacturing. Citi Pharma is dedicated to expanding its generic pharmaceutical portfolio and is actively engaged in research and development, notably in developing locally manufactured insulin to reduce import reliance. The company is also strategically advancing into biotechnology and oncology, driven by innovation and strategic collaborations, such as those with the Gates Foundation, to integrate advanced biotech technologies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material Information | 2022-02-18 | English | |
| Resolutions Passed in Annual General Meeting | 2021-12-29 | English | |
| Credit of Bonus Share Certificates | 2021-11-18 | English | |
| Transmission of Quarterly Report for the period September 30, 2021 | 2021-11-01 | English | |
| Financial Results for the first quarter ended September 30, 2021 | 2021-10-29 | English | |
| Transmission of Annual Report for the year ended June 30, 2021 | 2021-10-07 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
1 filing
| |||||
| 46592297 | Material Information | 2022-02-18 | English | ||
|
2021
10 filings
| |||||
| 46607540 | Resolutions Passed in Annual General Meeting | 2021-12-29 | English | ||
| 46617760 | Credit of Bonus Share Certificates | 2021-11-18 | English | ||
| 46632013 | Transmission of Quarterly Report for the period September 30, 2021 | 2021-11-01 | English | ||
| 46632640 | Financial Results for the first quarter ended September 30, 2021 | 2021-10-29 | English | ||
| 46656074 | Transmission of Annual Report for the year ended June 30, 2021 | 2021-10-07 | English | ||
| 46659023 | Notice of Annual General Meeting | 2021-10-07 | English | ||
| 46670791 | Financial Results for the year ended June 30, 2021 | 2021-09-30 | English | ||
| 46674609 | Material Information | 2021-09-16 | English | ||
| 46674721 | Decisions of Baord Meeting | 2021-09-13 | English | ||
| 46676919 | Decisions of the Board Meeting | 2021-08-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Citi Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/71782/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=71782 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=71782 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=71782 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 71782}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citi Pharma Ltd. (id: 71782)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.